Regen BioPharma Inc (RGBP)

[Skiluc]

All Molecules reacting with NR2F6 already patent protected (or applied for). By Regen. Way more important then the molecule itself(at least for investors here). Why would they need the molecules they already have secured with patents as having a controlled and measurable reaction with NR2F6 receptor? Undeniable.

One generally open program closing inside Eli Lilly doesnt effect Regen today one bit. Hilarious tho. Truly. Especially considering hiw many new programs open at the closure of one. Its a never ending open and close party folks. Lol

And now. Like never before. All mRNA is in absolutely historic demand. Us, with our thousands of lab hours and protected IP, is next. When current is my guess.

Watch.